Effects of Change in Blood Pressure on Retinal Capillary Rarefaction in Patients With Arterial Hypertension

Arterial Hypertension Clinical Trial

Official title:

Effects of Change in Blood Pressure on Retinal Capillary Rarefaction in Patients With Arterial Hypertension - a Pilot Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06098300
• Other study ID #: OPHT-240323
• Status: Recruiting
• Start date: September 1, 2023
• Est. completion date: August 2024

Study information

• Verified date: January 2024
• Source: Medical University of Vienna
• Contact: Gerhard Garhöfer, Assoc. Prof. Priv. Doz. MD
• Phone: 01 40400 29880
• Email: klin-pharmakologie[@]meduniwien.ac.at
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To evaluate whether in patients with initially poorly-controlled arterial hypertension, structural and functional differences in the retina and choroid remain after achieving a well-controlled blood pressure.

Description:

Optical Coherence Tomography Angiography (OCT-A) is an ocular imaging technique which allows fast and non-invasive assessment of the retinal microvasculature. With the OCT-A, a reduction in capillary density in patients with arterial hypertension has been found. In animal experiments, this so called retinal capillary rarefaction could be reversed after administration of antihypertensive medication. The main aim of the present study is to evaluate whether in patients with initially poorly-controlled hypertension, an increase in capillary density can be demonstrated, if patients achieve well-controlled blood pressure with antihypertensive medication. In addition changes in retinal oxygen metabolism and choroidal blood flow will be investigated.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: August 2024
• Est. primary completion date: August 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• Men and Women aged = 18 years
• Signed informed consent
• Apart from hypertensive retinopathy, normal ophthalmic findings
• Non-Smokers
• Patients with initially diagnosed or pre-existing mild to moderate primary arterial hypertension (systolic office blood pressure = 140 mmHg and/or diastolic office blood pressure = 90 mmHg)
• Planned initiation of antihypertensive medication or planned adaption of antihypertensive medication by the Department of Cardiology
• Subject agrees to perform regular blood pressure self-measurements and to document blood pressure values in a diary

Exclusion Criteria:

• Participation in a clinical trial in the three weeks preceding the study
• Blood donation in the three weeks preceding the study
• Symptoms of a clinically relevant illness in the three weeks preceding the study
• History of family history of epilepsy
• Secondary hypertension (e.g.: hyperaldosteronism, pheochromocytoma, renal artery stenosis, renal parenchymal diseases, Cushing-syndrome, Coarctatio aortae)
• History of hypertensive encephalopathy or intracerebral bleeding
• Diabetes mellitus Type 1 or Type 2
• Pregnant or breast-feeding women
• Women of childbearing potential (neither menopausal, nor hysterectomized, nor sterilized) not using effective contraception

Related Conditions & MeSH terms

• Arterial Hypertension
• Blood Pressure, High
• Hypertension
• Microvascular Rarefaction

Locations

Country	Name	City	State
Austria	Medical University of Vienna	Vienna

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

References & Publications (31)

Agabiti-Rosei E, Rizzoni D. Microvascular structure as a prognostically relevant endpoint. J Hypertens. 2017 May;35(5):914-921. doi: 10.1097/HJH.0000000000001259. — View Citation

Agrawal R, Gupta P, Tan KA, Cheung CM, Wong TY, Cheng CY. Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study. Sci Rep. 2016 Feb 12;6:21090. doi: 10.1038/srep21090. — View Citation

Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension. 1999 Apr;33(4):998-1001. doi: 10.1161/01.hyp.33.4.998. — View Citation

Blum M, Bachmann K, Wintzer D, Riemer T, Vilser W, Strobel J. Noninvasive measurement of the Bayliss effect in retinal autoregulation. Graefes Arch Clin Exp Ophthalmol. 1999 Apr;237(4):296-300. doi: 10.1007/s004170050236. — View Citation

Bosch AJ, Harazny JM, Kistner I, Friedrich S, Wojtkiewicz J, Schmieder RE. Retinal capillary rarefaction in patients with untreated mild-moderate hypertension. BMC Cardiovasc Disord. 2017 Dec 21;17(1):300. doi: 10.1186/s12872-017-0732-x. — View Citation

Chua J, Chin CWL, Hong J, Chee ML, Le TT, Ting DSW, Wong TY, Schmetterer L. Impact of hypertension on retinal capillary microvasculature using optical coherence tomographic angiography. J Hypertens. 2019 Mar;37(3):572-580. doi: 10.1097/HJH.0000000000001916. — View Citation

Chua J, Le TT, Sim YC, Chye HY, Tan B, Yao X, Wong D, Ang BWY, Toh DF, Lim H, Bryant JA, Wong TY, Chin CWL, Schmetterer L. Relationship of Quantitative Retinal Capillary Network and Myocardial Remodeling in Systemic Hypertension. J Am Heart Assoc. 2022 Mar 15;11(6):e024226. doi: 10.1161/JAHA.121.024226. Epub 2022 Mar 5. — View Citation

Chua J, Le TT, Tan B, Ke M, Li C, Wong DWK, Tan ACS, Lamoureux E, Wong TY, Chin CWL, Schmetterer L. Choriocapillaris microvasculature dysfunction in systemic hypertension. Sci Rep. 2021 Feb 25;11(1):4603. doi: 10.1038/s41598-021-84136-6. — View Citation

Dai H, Bragazzi NL, Younis A, Zhong W, Liu X, Wu J, Grossman E. Worldwide Trends in Prevalence, Mortality, and Disability-Adjusted Life Years for Hypertensive Heart Disease From 1990 to 2017. Hypertension. 2021 Apr;77(4):1223-1233. doi: 10.1161/HYPERTENSIONAHA.120.16483. Epub 2021 Feb 15. — View Citation

Dziedziak J, Zaleska-Zmijewska A, Szaflik JP, Cudnoch-Jedrzejewska A. Impact of Arterial Hypertension on the Eye: A Review of the Pathogenesis, Diagnostic Methods, and Treatment of Hypertensive Retinopathy. Med Sci Monit. 2022 Jan 20;28:e935135. doi: 10.12659/MSM.935135. — View Citation

Estato V, Obadia N, Carvalho-Tavares J, Freitas FS, Reis P, Castro-Faria Neto H, Lessa MA, Tibirica E. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats. Microvasc Res. 2013 May;87:41-9. doi: 10.1016/j.mvr.2013.02.007. Epub 2013 Mar 1. — View Citation

Frost S, Nolde JM, Chan J, Joyson A, Gregory C, Carnagarin R, Herat LY, Matthews VB, Robinson L, Vignarajan J, Prentice D, Kanagasingam Y, Schlaich MP. Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension. Sci Rep. 2021 Jan 13;11(1):1001. doi: 10.1038/s41598-020-79594-3. — View Citation

Hammer M, Vilser W, Riemer T, Schweitzer D. Retinal vessel oximetry-calibration, compensation for vessel diameter and fundus pigmentation, and reproducibility. J Biomed Opt. 2008 Sep-Oct;13(5):054015. doi: 10.1117/1.2976032. — View Citation

Jumar A, Harazny JM, Ott C, Kistner I, Friedrich S, Schmieder RE. Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients. J Clin Hypertens (Greenwich). 2016 Nov;18(11):1112-1118. doi: 10.1111/jch.12851. Epub 2016 Jun 16. — View Citation

Kurniawan ED, Cheung N, Cheung CY, Tay WT, Saw SM, Wong TY. Elevated blood pressure is associated with rarefaction of the retinal vasculature in children. Invest Ophthalmol Vis Sci. 2012 Jan 31;53(1):470-4. doi: 10.1167/iovs.11-8835. — View Citation

Lee WH, Park JH, Won Y, Lee MW, Shin YI, Jo YJ, Kim JY. Retinal Microvascular Change in Hypertension as measured by Optical Coherence Tomography Angiography. Sci Rep. 2019 Jan 17;9(1):156. doi: 10.1038/s41598-018-36474-1. — View Citation

Marschall S, Sander B, Mogensen M, Jorgensen TM, Andersen PE. Optical coherence tomography-current technology and applications in clinical and biomedical research. Anal Bioanal Chem. 2011 Jul;400(9):2699-720. doi: 10.1007/s00216-011-5008-1. Epub 2011 May 6. — View Citation

Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020 Apr;16(4):223-237. doi: 10.1038/s41581-019-0244-2. Epub 2020 Feb 5. — View Citation

Oh JS, Lee CH, Park JI, Park HK, Hwang JK. Hypertension-Mediated Organ Damage and Long-term Cardiovascular Outcomes in Asian Hypertensive Patients without Prior Cardiovascular Disease. J Korean Med Sci. 2020 Dec 14;35(48):e400. doi: 10.3346/jkms.2020.35.e400. — View Citation

Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation. 2003 Nov 4;108(18):2230-5. doi: 10.1161/01.CIR.0000095031.51492.C5. Epub 2003 Oct 13. — View Citation

Sabino B, Lessa MA, Nascimento AR, Rodrigues CA, Henriques Md, Garzoni LR, Levy BI, Tibirica E. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis. J Cardiovasc Pharmacol. 2008 Apr;51(4):402-9. doi: 10.1097/FJC.0b013e3181673bc5. — View Citation

Schrimpf C, Teebken OE, Wilhelmi M, Duffield JS. The role of pericyte detachment in vascular rarefaction. J Vasc Res. 2014;51(4):247-58. doi: 10.1159/000365149. Epub 2014 Sep 3. — View Citation

Shiga Y, Asano T, Kunikata H, Nitta F, Sato H, Nakazawa T, Shimura M. Relative flow volume, a novel blood flow index in the human retina derived from laser speckle flowgraphy. Invest Ophthalmol Vis Sci. 2014 May 29;55(6):3899-904. doi: 10.1167/iovs.14-14116. — View Citation

Sun C, Ladores C, Hong J, Nguyen DQ, Chua J, Ting D, Schmetterer L, Wong TY, Cheng CY, Tan ACS. Systemic hypertension associated retinal microvascular changes can be detected with optical coherence tomography angiography. Sci Rep. 2020 Jun 12;10(1):9580. doi: 10.1038/s41598-020-66736-w. — View Citation

Terheyden JH, Wintergerst MWM, Pizarro C, Pfau M, Turski GN, Holz FG, Finger RP. Retinal and Choroidal Capillary Perfusion Are Reduced in Hypertensive Crisis Irrespective of Retinopathy. Transl Vis Sci Technol. 2020 Jul 29;9(8):42. doi: 10.1167/tvst.9.8.42. eCollection 2020 Jul. — View Citation

Tian J, Marziliano P, Baskaran M, Tun TA, Aung T. Automatic segmentation of the choroid in enhanced depth imaging optical coherence tomography images. Biomed Opt Express. 2013 Mar 1;4(3):397-411. doi: 10.1364/BOE.4.000397. Epub 2013 Feb 11. — View Citation

Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020 Jun;75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. Epub 2020 May 6. No abstract available. — View Citation

Weber T, Arbeiter K, Ardelt F, Auer J, Aufricht C, Brandt MC, Dichtl W, Ferrari J, Foger B, Henkel M, Hohenstein-Scheibenecker K, Horn S, Kautzky-Willer A, Kepplinger E, Knoflach M, Koppelstatter C, Mache C, Marschang P, Mayer G, Metzler B, Oberbauer R, Obermair F, Obermayer-Pietsch B, Perl S, Pilz S, Prischl FC, Podczeck-Schweighofer A, Rebhandl E, Rohla M, Roller-Wirnsberger R, Saely CH, Siostrzonek P, Slany J, Stoschitzky K, Waldegger S, Wenzel RR, Weiss T, Wirnsberger G, Winhofer-Stockl Y, Zweiker D, Zweiker R, Watschinger B; Osterreichische Gesellschaft fur Hypertensiologie; Osterreichische Atherosklerosegesellschaft; Osterreichische Diabetes Gesellschaft; Osterreichische Gesellschaft fur Internistische Angiologie; Osterreichische Gesellschaft fur Nephrologie; Osterreichische Kardiologische Gesellschaft; Osterreichische Gesellschaft fur Neurologie; Osterreichische Schlaganfall-Gesellschaft; Osterr. Gesellschaft fur Allgemeinmedizin; Osterr. Gesellschaft fur Geriatrie; Osterreichische Gesellschaft fur Endokrinologie und Stoffwechsel; Osterreichische Gesellschaft fur Innere Medizin; Osterreichische Gesellschaft fur Kinder- und Jugendheilkunde. [Austrian Consensus on High Blood Pressure 2019]. Wien Klin Wochenschr. 2019 Nov;131(Suppl 6):489-590. doi: 10.1007/s00508-019-01565-0. German. — View Citation

Werkmeister RM, Schmidl D, Aschinger G, Doblhoff-Dier V, Palkovits S, Wirth M, Garhofer G, Linsenmeier RA, Leitgeb RA, Schmetterer L. Retinal oxygen extraction in humans. Sci Rep. 2015 Oct 27;5:15763. doi: 10.1038/srep15763. — View Citation

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; Authors/Task Force Members:. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018 Oct;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940. Erratum In: J Hypertens. 2019 Jan;37(1):226. — View Citation

Wong TY, Mitchell P. The eye in hypertension. Lancet. 2007 Feb 3;369(9559):425-35. doi: 10.1016/S0140-6736(07)60198-6. Erratum In: Lancet. 2007 Jun 23;369(9579):2078. Wong, Tien [corrected to Wong, Tien Yin]. — View Citation

* Note: There are 31 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in retinal vessel density after achieving blood pressure treatment target (OCT-A).	As OCT devices are able to calculate the movements of erythrocytes, retinal perfusion can be visualized with Optical Coherence Tomography Angiography. No contrast media is necessary for the representation of retinal vessels.	12 weeks
Secondary	Change in choroidal vascularity index after achieving blood pressure treatment target (EDI-OCT).	The choroid will be imaged with the enhanced-depth-imaging-OCT (EDI-OCT) (Spectralis, Heidelberg Engineering, Heidelberg, Germany). By using an automatic detection algorithm, developed by Tian et al., the choroid will be separated from the sclera and Bruch´s membrane. Afterwards, the image will be binarized using the software Fiji ImageJ. An autolocal threshold will be applied and the image will be converted into an RGB (red, green, blue) image, thereby determining the luminal area of the choroid. The choroidal vascularity index is obtained by dividing the luminal area by the total choroidal area.	12 weeks
Secondary	Change in neurovascular coupling after achieving blood pressure treatment target (DVA).	The DVA allows for the real time measurement of retinal vessel diameters in vivo. The DVA is a commercially available system (IMEDOS, Jena, Germany) which comprises a fundus camera, a video camera, a real time monitor and a personal computer with an analyzing software for the accurate determination of retinal arterial and venous diameters. Every second a maximum of 25 readings of vessel diameter can be obtained. For this purpose the fundus is imaged onto the charge coupled device chip of the video camera. The consecutive fundus images are digitized using a frame grabber. In addition, the fundus image can be inspected on the real time monitor and, if necessary, stored on a video recorder. Evaluation of the retinal vessel diameters can either be done online or offline from the recorded video tapes.	12 weeks
Secondary	Change in retinal oxygen saturation after achieving blood pressure treatment target (DVA).	Retinal oxygen saturation measurement is based on the image analysis by the oxygen module of the commercially available Dynamic Vessel Analyzer (DVA, Imedos, Germany). Two monochromatic fundus images are recorded by the retinal oximeter. In an image, obtained by the camera and filter assembly, the operator has to mark the vessel of interest by a mouse click. The vessel is traced automatically applying the following procedure. The vessel walls are located as photometric edges in the vicinity of the mouse cursor in the green channel image. If edges are determined, the search is continued in their proximity.	12 weeks
Secondary	Change in ocular blood flow after achieving blood pressure treatment target (LSFG).	A commercially available LSFG (Nidek, Japan) system will be used in the present study. The LSFG device consists of a fundus camera equipped with a diode laser with a wavelength of 830 nm and a charge-coupled device. NB, the relative velocity of blood flow, is derived from the pattern of speckle contrast produced by the interference of a laser scattered by blood cells moving in the ocular fundus. Images are acquired continuously at the rate of 30 frames per seconds in a 4-second time period and stored on a personal computer. Equipped analysis software synchronizes the captured MBR images in each cardiac cycle, and averages the MBR in each heartbeat to produce a heartbeat map of the ONH and the retina/choroid.	12 weeks
Secondary	Change in retinal oxygen extraction after achieving blood pressure treatment target.	Retinal oxygen extraction will be determined by measuring retinal blood flow (LSFG), retinal oxygen saturation (DVA) and retinal vessel diameter (DVA). For the calculation of retinal oxygen extraction, the formula of Werkmeister et al. will be used, which will be slightly modified as retinal blood flow is measured with LSFG and not with Doppler OCT.	12 weeks
Secondary	Change in ocular perfusion pressure and arterial blood pressure after achieving blood pressure treatment target.	mOPP = 2/3 mBP- IOP Blood pressure will be measured with an automated oscillometric device	12 weeks
Secondary	Change in retinal vessel diameter after achieving blood pressure treatment target (DVA).	Two monochromatic fundus images are recorded by the retinal oximeter. In an image, obtained by the camera and filter assembly, the operator has to mark the vessel of interest by a mouse click. The vessel is traced automatically applying the following procedure. The vessel walls are located as photometric edges in the vicinity of the mouse cursor in the green channel image. If edges are determined, the search is continued in their proximity.	12 weeks

External Links

•   Burk A, Burk R. Optische Kohärenztomografie (Optical Coherence Tomography, OCT). In: Burk A, Burk R, editors. Checkliste Augenheilkunde. 7., vollständig überarbeitete Auflage ed: Georg Thieme Verlag KG; 2023.
•   Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibiriçà E. Increased Skin Capillary Density in Treated Essential Hypertensive Patients*. American Journal of Hypertension. 2006;19(5):477-83.
•   Description: Medical University of Vienna, Department of Clinical Pharmacology